Latest News about Briefs
Recent news which mentions Briefs
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
November 11, 2024
From Benzinga
EHang, Enpower Team Up On Next-Gen eVTOL Tech: Details
November 11, 2024
From Benzinga
Cigna Not Pursuing Humana Merger, Stock Soars
November 11, 2024
From Benzinga
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
November 11, 2024
From Benzinga
Monday.com Stock Tanks Despite Q3 Beat, Raised Outlook
November 11, 2024
From Benzinga
Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook
November 11, 2024
From Benzinga
Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More
November 11, 2024
From Benzinga
ASML's IT Outage Affected Chipmaking Operations Worldwide
November 11, 2024
From Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
November 11, 2024
From Benzinga
From Benzinga
From Benzinga
Asia Mixed And Europe Up, Dollar Gains To 3-Month High - Global Markets Today While US Slept
November 11, 2024
From Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
November 09, 2024
From Benzinga
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
Bath & Body Works Stock Downgraded Due To This Risk: Details
November 08, 2024
From Benzinga
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
November 08, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside
November 08, 2024
From Benzinga
Lucid's Delivery Gains, New SUV Can't Shake Profit Concerns
November 08, 2024
From Benzinga
What's Going On With XPeng Stock Friday?
November 08, 2024
From Benzinga
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
November 08, 2024
From Benzinga
Trump Says He Won't Sell Trump Media Stock
November 08, 2024
From Benzinga
Tesla's China Sales Plunge to 6-Month Low In October, Exports Rise
November 08, 2024
From Benzinga
Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
November 08, 2024
From Benzinga
Wingstop's Strong Unit Economics - Goldman Sachs Upgrades Stock
November 08, 2024
From Benzinga
Upstart's Enhanced Lending Model Drives Revenue Growth, Analyst Sees Further Upside Potential
November 08, 2024
From Benzinga
EPAM Inks Strategic Deals, Enjoys Robust Tax Benefits: Analyst
November 08, 2024
From Benzinga
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
From Benzinga
Nvidia Taps Former NASA Astronaut To Enhance Board
November 08, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.